z-logo
open-access-imgOpen Access
IL-1β Expression of Patients with Chronic Rhinosinusitis is negatively correlated with Lund-Mackay score
Author(s) -
Lidya Turupadang,
Muhammad Fadjar Perkasa,
Abdul Qadar Punagi,
Azmi Mi'rah Zakiah,
Burhanuddin Bahar
Publication year - 2022
Publication title -
n (nusantara) medical science journal
Language(s) - English
Resource type - Journals
eISSN - 2597-7288
pISSN - 2460-9757
DOI - 10.20956/nmsj.v6i2.18765
Subject(s) - nasal polyps , medicine , chronic rhinosinusitis , gastroenterology , correlation , sinusitis , proinflammatory cytokine , immunohistochemistry , surgery , inflammation , mathematics , geometry
IL-1β is one of the proinflammatory cytokines which is commonly found in various diseases, including Chronic Rhinosinusitis (CRS). It has been widely targeted as a therapeutic approach for inflammatory diseases. However, study of IL-1β expression and its correlation with CT-Scan grading scores in CRS is still scarce. Objective: To investigate IL-1β expression based on immunohistochemical examination and analyse its correlation with Lund-Mackay score in CRS with and without polyps. Method: This analytic observational study was done on 50 patients: 25 subjects in the CRS with Nasal Polyps (CRSwNP) group and 25 subjects in the CRS without Nasal Polyps (CRSsNP) group. The uncinate process was taken for immunohistochemical examination of IL-1β. Lund-Mackay score was calculated based on CT-Scan of the paranasal sinus. Result: IL-1β expression in CRSsNP (mean=36.38) was significantly higher than that in the CRSwNP (mean=14.62) with p<0.001. Lund-Mackay score in CRSwNP was higher (mean=35.22) compared to CRSnNP group (mean=15.78) with p<0.001. There was a moderate negative correlation (-0.403) between IL-1β expression and Lund-Mackay score (p<0.05). Conclusion: There was a moderate negative correlation between IL-1β expression and Lund-Mackay score. The IL-1β and the Lund-Mackay score in CRSwNP were lower and higher, respectively, than in CRSsNP

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here